THE HIGHLIGHTED ARTICLE IN
Journal of Neurological Surgery Part A
Issue 06 · Volume 83 · November 2022
手术切除是颅底脑膜瘤 (SBM) 的主要治疗方法。 鉴于高复发率,应考虑辅助放射治疗 (RT) 治疗。 本研究的目的是评估无进展生存期 (PFS)、总生存期 (OS) 和预后因素调节结果。
Original Article
Federico Pessina, Pierina Navarria, Zefferino Rossini, Elena Clerici, Maurizio Fornari, Letterio S. Politi, Marta Scorsetti, Franco Servadei
Patients receiving surgical resection for grade I SBMs were included. The extent of resection (EOR) was dichotomized as gross total resection (GTR) and subtotal resection (STR). RT was administered only in patients receiving STR. Clinical outcome was evaluated by brain magnetic resonance imaging (MRI) performed every 6 months for the first year and yearly thereafter.